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The etiology of rheumatoid arthritis remains unknown. Increasing evidence, 
however,  indicates that both  cellular and  humoral immunity are  involved in 
maintaining the chronicity of inflammation in this disease (1). The involvement 
of humoral immunity is largely through the formation of immune complexes. 
The predominant immune complexes contain rheumatoid factors (RF), l which 
are antibodies directed to antigenic determinants on the Fc region of IgG. These 
antibodies may belong to any class  of immunoglobulins, and are  termed IgG 
rheumatoid factors (IgG-RF), IgM rheumatoid factors (IgM-RF), etc. Self-asso- 
ciating IgG-RF form unique immune complexes  in  that  these  IgG molecules 
serve as both antigens and antibodies. These molecules form the intermediate 
complexes in the sera (2),  and have been isolated from the synovial fluids (F. 
Nardella,  D.  C.  Teller, and M.  Mannik, unpublished results)  of patients with 
rheumatoid arthritis. IgG-RF are the most prevalent antibodies synthesized by 
plasma cells in the human rheumatoid synovium (3-5).  Furthermore, the IgG- 
RF can drive inflammation by activation of  complement (6, 7), and by interaction 
with  human  monocytes  (8).  Why  rheumatoid  factors  arise  in  patients  with 
rheumatoid arthritis and in other diseases is unknown. 
Previous studies (reviewed in 9) have shown that the antigenic specificities of 
IgM-RF are  directed to  either nongenetic or  genetic antigenic determinants. 
Some of these determinants were identified on the C'y3 domain, and others were 
inferred to be on the C~,2 domain. The Ga nongenetic antigenic determinant 
was most prevalent, and  was present  on all  IgG subclasses except  IgG3  (10). 
Previous studies from this laboratory (1 1)  have shown that identical antigenic 
determinants for IgG-RF were present on the Fc fragments of normal IgG and 
IgG-RF, and were absent from the C~,3 domain. Knowledge of the antigenic 
determinants for IgG-RF in molecular detail might provide a clearer picture of 
the mechanism of self-association of these molecules, and provide clues to the 
initiation of RF production. 
We now have determined the site on the IgG molecule that is involved in the 
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self-association of IgG-RF, and  have shown  that  it is in  the  same location  and 
involves some of the same amino acid side chains as the site that binds staphylo- 
coccal protein A  (SPA).  SPA is found in the cell wall of most strains of Staphylo- 
coccus aureus.  It has a molecular mass of 42 kilodaltons (kD), and has four highly 
homologous regions, each able to bind to the Fc regions of the IgG from various 
species.  In man, SPA binds to the Fc regions of human subclasses IgG1, -2, and 
-4, but not IgG3 (reviewed in  12).  The complex of an SPA monovalent subunit, 
fragment B, with human Fc has been crystallized, and the amino acid side chains 
involved  in  the  binding  determined  by  x-ray  crystallography  (13,  14).  The 
coincidence of binding sites for IgG-RF and  SPA suggests new approaches for 
study of the etiology of rheumatoid arthritis. 
Materials and  Methods 
Affinity Isolation oflgG-RF.  IgG-RF was isolated from the plasma of patients JJ and EG 
by affinity chromatography on  human  monomeric IgG-agarose columns.  The  human 
monomeric IgG columns were prepared as described previously (11).  The columns were 
equilibrated at 4°C in pH 8.8 borate buffer (0.2 M borate, 0.15 M NaCI) to minimize the 
nonspecific adsorption  of non-RF  IgG (15).  This  pH also,  as shown  below,  results  in 
maximum interaction energy of the RF-antigen bond.  1-3 ml of JJ or EG plasma were 
applied to the affinity columns equilibrated in the starting buffer. RF were eluted with 
acetate buffer (0. I M acetate, pH 3.5) after washing the columns with ~400 ml of starting 
buffer.  The  columns  were  cycled  through  the  starting  and  eluting  buffers  until  the 
absorbance at 280  nm of the acid cycle was <0.003.  The pH 3.5  acetate eluates were 
pooled and concentrated using stirred, positive pressure concentrators with Diaflow YM 
10 membranes (Amicon Corporation, Lexington, MA). The IgG-RF from patient JJ were 
further purified by gel filtration on a Sepharose S-300 column (Pharmacia Fine Chemicals, 
Piscataway, NJ) equilibrated in phosphate buffer (0.05  M phosphate, 0.15  M  NaCI, pH 
7.3). The affinity isolates from patient EG were further purified by gel filtration on an S- 
300 column equilibrated in 0. I  M acetate buffer to remove the IgM-RF. The IgG peak 
was  pooled,  concentrated,  and  applied  to an  S-300  column  equilibrated  in  phosphate 
buffer.  The  resultant  IgG-RF were pooled  and  concentrated  as described above and, 
contained <5%  IgM and IgA, as determined by radial immunodiffusion (Immunoplate 
III; Travenol Laboratories, Inc., Costa Mesa, CA). F(ab')2 fragments were prepared from 
the  isolated IgG-RF by pepsin digestion and subsequent Sepharose S-300 gel filtration 
with the column equilibrated in acetate buffer. JJ Fab fragments were prepared from the 
isolated complexes as described previously (11). 
Preparation of Human IgG and IgG Fragments.  Human IgG was prepared from Cohn 
fraction  II (Miles  Laboratories,  Inc.,  Elkhart,  IN) by DEAE-Sephacel  (Pharmacia Fine 
Chemicals) ion-exchange chromatography in 0.1  M Tris buffer, pH 8.6.  Human F(ab')2 
and pFc'  fragments were prepared and  isolated from human  IgG, and human  Fc was 
prepared and isolated from papain-digested IgG, both as described previously (11). Rabbit 
IgG was prepared from rabbit Cohn fraction II (Miles Laboratories, Inc.) by gel filtration 
on an S-300  column  equilibrated  in  borate buffer.  Rabbit  F(ab')2 and  pFc' fragments 
were prepared from Cohn fraction  II by pepsin digestion (16) and S-300 gel filtration. 
Rabbit  Fc  fragments were prepared and  isolated from rabbit Cohn  fraction  II by the 
method of Porter (17).  Rabbit  Facb fragments were prepared and isolated from Cohn 
fraction II by a modification of the method of Connell and Porter (18).  380 mg of rabbit 
Cohn fraction II was dissolved in  14 ml of 0.04 M acetate buffer at pH 5.5. The pH was 
lowered to 2.5 with  1 M HCI and allowed to incubate for 15 minutes at 37°C.  The pH 
was raised to 7.3 with  1 M NaOH and 4.32 mg of porcine plasmin (Sigma Chemical Co., 
St.  Louis, MO) was added.  After incubation for 30 min at 37°C, the digestion mixture 
was immediately gel filtered on a  G-200 column (Pharmacia Fine Chemicals) in 0.05  M 
phosphate buffer at  4°C.  The initial peak was pooled,  concentrated  to  22  ml using a 
stirred,  positive pressure  concentrator  with  YM  10  membranes, dialyzed  into  0.01  M NARDELLA ET  AL.  1813 
sodium  acetate,  pH  5.5,  and  applied  to a  CM  52  cation-exchange column (Whatman 
Chemicals, Maidstone, Kent, United Kingdom) in the same buffer. The Facb-containing 
peak was the  second peak  to emerge in a  0.01-0.1  M  sodium acetate,  pH  5.5,  linear 
gradient.  This peak was pooled and concentrated, and applied to CL 4 B SPA column 
(Pharmacia Fine Chemicals) to remove any remaining intact IgG. Human IgG3 McD and 
EV were prepared from plasma by starch block electrophoresis and S-300 gel filtration of 
the monoclonal peaks. 
Staphylococcal Protein A.  SPA was obtained from Pharmacia Fine Chemicals,  and from 
IMRE Corp. (Seattle,  WA). Fragment D of SPA was obtained from J. Sj6quist  (University 
of Uppsala, Sweden). 
Chemical Modifications of lgG and IgG RF.  Chemical modification of histidines  in IgG 
and IgG-RF was done with diethyipyrocarbonate (19).  The modifications were followed 
spectrophotometrically, and  reversed  with  hydroxylamine.  Modification of lysines  was 
done by reductive methylation at pH 9 using formaldehyde as the carbonyl donor and 
sodium borohydride as the reductant (20).  The degree of amino group substitution was 
determined by trinitrobenzene sulfonic acid assay (21). Modification of tyrosines was done 
with tetranitromethane (22) and N-acetylimidazole (23). The degree of modifications was 
determined spectrophotometrically. The N-acetylimidazole modifications were reversed 
with hydroxylamine. 
pH Titration Studies.  A pH titration for the interaction of Fab fragments ofJJ IgG-RF 
and normal IgG was done by high-speed sedimentation equilibrium ultracentrifugation. 
The ultracentrifugation  techniques  have been  described  previously (11).  The  Fab  RF 
fragments and normal human IgG, at a molar ratio of 2:1, were dialyzed against 0.05 M 
phosphate buffer at the appropriate pH. Phosphate buffers were kept at a constant ionic 
strength of 0.28 OsM by varying the concentration of NaCl. The buffers were rendered 
0.005 M in acetate between pH 4.35 and 4.85, and 0.005  M in ethanolamine between 
pH 8.85 and  10.35, to maintain buffering capacities.  Three samples  with initial  protein 
concentrations of 1.0,  0.7,.and 0.4 mg/ml were centrifuged at  15,000 rpm for 24 h at 
20°C at each of the pH values tested between pH 4.35 and  11.35. The partial specific 
volumes for both components were assumed to be 0.738 ml/g (24).  Using a  molecular 
mass of 47.1  kD for JJ Fab, and  141.7 kD for IgG, as determined by analytical ultracen- 
trifugation, the data were analyzed for complex formation by the method of Benhke et 
al. (25) to obtain equilibrium constants for the 1:1 complex formed by the two reactants. 
It was previously shown (11) that the antigenic valence for normal IgG in this interaction 
is one. The equilibrium constant at each pH is K~ =  [Fab-IgG]/[Fab][IgG]. For the linked 
function analysis,  the reaction is considered to be reactants ~  products. The data were 
fitted as log Kc = cst +  Y~proa  .... np log (Kp +  [H+]) -  Y~  ........ nr log (Kr +  [H+]), where cst 
is the value of log Kc at high pH. Kp and K~ are proton dissociation constants, pH titrations 
were also  done for interactions of intact radiolabeled JJ  IgG-RF and EG IgG-RF, with 
normal  IgG using  a  solid-phase  equilibrium  radioimmunoassay described  below.  The 
percent binding of 7  x  10  -9 M radiolabeled JJ  IgG-RF or 7 X  10  -l° M EG  IgG-RF to 
aggregated IgG bound to the test tubes,  expressed as  7 x  10  -8 M IgG monomers, was 
determined at the various pH in the same buffers used for the analytical ultracentrifuga- 
tion experiments. The percent binding of radiolabeled JJ RF or EG RF were corrected 
for nonspecific binding by subtraction of binding of normal, radiolabeled IgG to the IgG 
coated tubes.  Under these circumstances, with low percent binding of RF, the value of 
log Kc, the association constant for complex formation, should be proportional to the log 
of the percent binding, to a first approximation. We found that log K¢ =  S log P  fitted 
the data most smoothly, where P is the corrected percent binding of IgG RF to the test 
tubes, and S is the scale factor, determined as a maximum likelihood estimate parameter 
together with the equilibrium constant parameters. 
Solid-phase  Equilibrium  Radioimmunoassay.  For  the  inhibition  radioimmunoassays, 
101-193 ng of 125I-jJ IgG-RF, or 51-110 ng of 12~I-EG IgG-RF (previously determined 
to result in maximum percent bindings) in a reaction volume of 100 ~1 were mixed with 
increasing concentrations of inhibitors in borate buffer, with 0.1% bovine serum albumin, 
and added to polypropylene tubes previously coated for 2.5 h at room temperature with 1814  IgG  RHEUMATOID  FACTOR  AND  STAPHYLOCOCCAL  PROTEIN  A 
2  mg/ml heat-aggregated human  IgG.  Heat-aggregated human  IgG was prepared  by 
heating IgG obtained as described above for  15  min at 63°C.  The remainder of the 
adsorptive sites were blocked with 0.1% bovine serum albumin in borate buffer for 90 
min before adding the mixtures of IgG-RF, with or without inhibitors. The IgG-coated 
tubes with the mixtures were stored overnight at 4°C, after which the top (T) half were 
removed from the bottom (B), both halves  counted in an automatic well-type  gamma 
counter, and the percent binding determined as 1  O0 x  (B -  T)/(B + T). The assays were 
performed  in  triplicate,  converted  to  100%  on  the  ordinate  for  ease  of interassay 
comparisons, and expressed as mean +  SEM. The observed data were fit to the binding 
equation P = [(KDs0 X Pm~,) + (I X Pma,)]/(KDso + I), where P is the percent binding, Pmio 
is the asymptote at low I, Pmax is the asymptote at high I, KDs0 represents the dissociation 
constant, and is equal to I  when P  is 50%  of control binding; I  is the concentration of 
inhibitor.  The  fitting was  accomplished with a  computer program  using a  weighted 
nonlinear least squares function. For weak inhibitors, KDs0 expressed in the tables are 
extrapolated values,  when a computer fit could be obtained. For direct-binding assays, 
the binding of the radiolabeled IgG RF to the solid-phase  IgG were studied over a range 
of 100-1,000 ng. The other details of the assay are as described for the inhibition assays. 
Computer Drawing of Stereo Pair Diagram of V2Fc.  The stereo pair diagram of Y~Fc, 
showing the amino acid side chains involved in the binding of SPA, was drawn on an AED 
767 high-resolution color rastergraphics terminal using a VAX 11/780 computer and the 
MOMUS program. The program MOMUS (Multiport molecular structure drawing and 
comparison program) was written by K. Watenpaugh of the Department of Biological 
Structure, University of Washington. 
Results 
Localization of Antigenic Determinants to IgG Domains.  We used a  solid-phase 
equilibrium radioimmunoassay to examine the interaction of IgG-RF with anti- 
gens. In this assay, purified, radiolabeled IgG-RF or F(ab')2 fragments of IgG- 
RF were allowed to bind to solid-phase human IgG. The inbibition of this binding 
was examined with a  variety of preparations.  The degree of inhibition reflects 
the presence of appropriate antigenic determinants on the test substance.  The 
binding of IgG-RF could be readily inhibited by intact human or rabbit IgG, as 
well as by Fc fragments of these proteins, although a  difference was observed 
between the two IgG-RF with rabbit IgG and Fc. In contrast, F(ab')2 fragments, 
Facb fragments (this  fragment of rabbit  IgG contains all domains except C3,3 
[14]) and pFc'  fragments (C"},3 domains of IgG) were poor inhibitors (Table  I 
and Fig.  1). Thus, the RF did not interact with the C~,2 or C3,3  domains alone, 
but required the presence of botb domains. It had already been shown (11) that 
normal Fc fragments and Fc fragments from IgG-RF reacted identically with the 
F(ab')2 fragments of IgG-RF by sedimentation equilibrium ultracentrifugation, 
demonstrating  that  unique  antigenic  determinants  did  not  exist  on  the  Fc 
fragments of IgG-RF. 
A previously recognized antigenic determinant for IgM-RF is present (10) on 
subclasses IgG1, -2, and -4, and is absent from IgG3.  The two IgG3 myeloma 
proteins tested in these studies were ineffective inhibitors of the binding of the 
IgG-RF to solid-phase IgG (Table I and Fig.  1). This finding suggested that the 
antigenic determinant for self-association of IgG-RF may be comparable to the 
so-called Ga site for IgM-RF. 
As  already  noted,  SPA  also  binds  human  IgG1,  -2,  and  -4,  and  not  IgG3 
(reviewed  in  12).  SPA  and  its  active  monovalent subunit,  fragment D  (7  kD) 
readily inhibited the binding of the F(ab')~ fragments of both IgG-RF to solid- NARDELLA  ET  AL.  1815 
TABLE  I 
Inhibition of Binding of 125I-JJ and -EG IgG-RF to Solid-phase IgG 
by Human and Rabbit IgG, IgG Fragments, and SPA 
KDso (-+-SE) 
Inhibitor 
EG 
t~M 
Human IgG  1.45 -  0.49  0.60 +  0.21 
Human Fc  2.43 ±  0.14  1.34 ±  0.25 
Human F(ab')2  103 ±  140"  74.0 +  275* 
Human pFc'  116 ±  33.2*  86.1  ±  17.7" 
Rabbit IgG  4.06 _+  1.13"  0.29 _  0.07 
Rabbit Fc  7.36 _  1.80"  1.04 +  0.49 
Rabbit F(ab')~  30.01  _  3.34*  15.18 _+ 8.42* 
Rabbit pFc'  No inhibition  37.40 ±  11.52" 
Rabbit Facb  12.76 ±  1.97"  17.98 +  8.25* 
Human IgG3 McD  5.03 _  1.81"  8.22 +  2.73* 
Human lgG3 EV  6.61  __. 1.90"  4.95 _+  1.22" 
SPA  0.02 ±  0.003  0.01  4- 0.004 
Fragment D of SPA  0.05 ___ 0.01  0.15 4- 0.04 
The following molecular masses (kD) were used in calculation of molar 
concentrations of human and rabbit IgG and IgG fragments: IgG, 150.0; 
Facb,  125.0;  F(ab')~,  100.0;  Fc,  50.0;  and pFc', 25.0.  A  small  KDs0 
indicates a good inhibitor, and conversely a large KDs0 indicates a poor 
inhibitor. 
* Extrapolated KDn0. See legend to Fig.  1. 
phase  IgG  by  binding  to  the  IgG  and  thus  preventing  binding  of the  RF 
preparations (Table I and Fig. 1). 
Collectively, these experiments indicated that the antigenic determinant for 
self-association of IgG-RF required intact C~,2 and C~3 domains, may be com- 
parable to the Ga antigenic determinant described for IgM-RF, and may involve 
the same region that binds SPA. 
pH Titration Studies.  To obtain information regarding the specific amino acid 
residues  involved in  the  IgG-RF-antigen  interactions,  a  pH  titration  for  the 
interaction of Fab fragments ofJJ IgG-RF and normal IgG was done by high- 
speed  sedimentation equilibrium  ultracentrifugation,  pH  titrations  were  also 
done for the interactions of intact, radiolabeled JJ and EG IgG-RF with normal 
IgG using the solid-phase equilibrium radioimmunoassay. If an ionizable amino 
acid side chain was involved in the RF-antigen interactions, then protonation or 
deprotonation would perturb them at a pK characteristic of the involved group. 
The same plateaus and inflections were present in the plots obtained by radioim- 
munoassays as in the ultracentrifuge study, indicating that the processes occur- 
ring in the radioimmunoassay were the same as those measured by sedimentation 
equilibrium uitracentrifugation. Changes in the binding occurred with apparent 
pK  (pKapp) of 5.0,  7.0, and 10.4 (Fig.  2, A and B) indicating the involvement of 
Asp and Giu, His, and Lys or Tyr respectively for both IgG-RF. The carboxylate 
involvements were  not pursued further,  since low pH  dissociates RF-antigen IgG  RHEUMATOID  FACTOR  AND  STAPHYLOCOCCAL  PROTEIN  A  1816 
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FTGURE  1.  Inhibition of binding of ~5I-JJ (A and B) and -EG (C and D) IgG-RF or F(ab')2- 
RF to solid-phase lgG by human IgG (O), human Fc (A), human pFc' (O), human IgG3 McD 
(ffl), and SPA (e). The KDs0 +  SE are represented as the horizontal bars at the midpoints of 
the fitted curves. For weak inhibitors, the KD~0 expressed in the tables are extrapolated values, 
estimated when a computer fit could be obtained. 
interactions and induces conformational changes that are difficult to distinguish 
from  discrete  carboxyl  group  involvement.  The  putative  lysyl  residues  were 
eliminated by chemical modification studies as shown below. Thus, histidyl and 
tyrosy[ residues are the important determinants of the neutral and alkaline areas 
of the pH  titration.  The  number of groups involved could not be determined 
from the data.  For the purposes of curve fitting, two carboxylate, three histidyl, 
and two tyrosyl residues were chosen for the linked-function model represented 
in Fig. 2 C. Independent of the model used, ionization of His decreases complex 
formation, as does ionization of tyrosine. The direction of the pK shifts implies 
that His and Tyr are buried in complex formation. 
Chemical Modification Studies.  The  pH  titration  studies  of the  IgG-RF and 
IgG interactions  described above indicated that amino acid side chains of histi- 
dines  and  lysines and/or  tyrosines  were  involved.  To  determine  whether  the 
histidine residues involved were on the antigen or antibody sides of the interac- 
tions, chemical modification of IgG and the IgG-RF was done with diethylpyro- 
carbonate.  The  modifications  were  followed  spectrophotometrically,  and  re- 
versed with hydroxylamine (19). The preparations  treated with diethylpyrocar- 
bonate  showed  no  evidence  of tyrosine  modification,  as  determined  by  the 
absence of changes in optical absorbance at 278 nm. 
With  increased  modification  of histidines  on  IgG,  its  ability  to  inhibit  the 
binding  of IgG-RF  was  decreased.  Furthermore,  when  the  lower  degrees  of 
modification were reversed with hydroxylamine, the inhibitory activities of IgG 
were recovered (Table II).  The reversal  of heavily modified IgG could not be NARDELLA ET  AL.  1817 
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FIGURE 2.  pH  dependence  of the  interaction  of RF  with  normal  IgG.  (A)  Equilibrium 
constants  determined  by high-speed  sedimentation  equilibrium  ultracentrifugation  for the 
interaction of Fab fragments ofJJ IgG-RF and normal human IgG, at a molar ratio of 2:1 in 
0.05 M phosphate buffer at the appropriate pH. Three samples with initial protein concentra- 
tions of 1.0, 0.7, and 0.4 mg/ml were centrifuged at  15,000  rpm for 24 h at 20°C at each 
pH. The line drawn in  the figures  is for the model in C.  Independent of the numbers of 
groups  on  the  model,  the  midpoint  pH  of the  decrease  in  the  alkaline  range  is  10.4, 
corresponding to lysyl or tyrosyl residue(s). The midpoint pK in the neutral range is 7.0, and 
corresponds to histidyl residue(s); the drop in log K at the very lowest pH values corresponds 
to carboxylate (Asp or Glu) residues. (B) pH dependence of RF binding by radioimmunoassay. 
The percent binding of radiolabeled  JJ RF (©) (7 x  10  -9 M) or EG RF (Q) (7 x  10  -l° M) at 
various  pH  were  corrected for nonspecific  binding  by subtraction  of binding of normal, 
radiolabeled  IgG to the IgG-coated tubes. The molar amount of aggregated IgG bound to the 
test  tubes as antigen was 7 x  10  -s M, expressed  as IgG monomers. Both IgG-RF behaved 
identically in this analysis. The line drawn in the figure is for the same model and parameters 
as in A. (C) Model used for fitting the data in A and B. Numbers associated with the horizontal 
equilibria  are pKa values; numbers adjacent to the vertical arrows are log K values for these 
equilibria.  In this particular model, two carboxylate,  three histidyl, and two tyrosyl residues 
were assumed, as denoted by the subscripts of  H for the reactants (R) and products (P). Other 
models with different numbers of dissociable protons fit the data almost as well as the model 
shown. 
achieved,  presumably  because  of formation  of dimodified  histidyl  residues.  In 
contrast,  the  modifications  of histidines  on  IgG-RF caused  no or only minimal 
decrease  in  binding  of these  molecules  to  the  antigen  (Table  III).  These  data 
indicate that the histidines involved in these antigen-antibody interactions are on 
the antigen  molecules.  Six  histidine  residues  exist  on  the  Fc portion  of each  3' 
chain of IgG1  EU (26). Two of these (His 268 and His 285) are not in the C3'2- 
C3"3  interface  region  (27),  and  are  unlikely  to  be  involved.  Histidine  429  is 
inaccessible  to solvent.  Thus,  one or more of the three  His residues  in the C3"2- 
C3"3 interface (310,  433,  and 435) are involved (Fig.  3A).  These same histidine 
residues  are  involved  in  the  binding  of SPA  to human  IgG (13,  14)  (Fig.  3,  B 
and  C).  Molecules  of  the  IgG3  subclass  do  not  bind  SPA  because  of  the 
substitutions  of arginine  and  phenylalanine  for histidine  435  and  tyrosine  436 
(13,  14).  IgG3  poorly  inhibited  the  binding  of both  IgG-RF,  as  noted  above, 
indicating that His 435, and one or both of His 433 and 310 are involved in the 
binding. 
Reductive methylation of IgG and the IgG-RF was done to determine if lysines 
were involved, and, if so, whether they were stationed on the antigen or antibody 
sides of the interactions.  Reductive methylation was accomplished at pH 9  using 
formaldehyde as the  carbonyl donor  and  sodium  borohydride  as the reductant 
(20). Under these conditions, stable dimethylamino groups are formed and other 
side  chain  groups  do  not  give  stable  derivatives.  As  assessed  by  ultraviolet 1818  IgG  RHEUMATOID  FACTOR  AND  STAPHYLOCOCCAL  PROTEIN  A 
TABLE  II 
Inhibition of Binding of '251-].] and -EG IgC-ne to Solid-phase IgG by Chemically Modified 
Human lgG 
Modification 
~3  EG 
Degree of  Degree of 
modifica-  KDs0 (±SE)  modifica- 
tion  tion 
KD~o (±SE) 
%  ~  %  uM 
Unmodified IgG  --  1.45  +  0.49  --  0.60 +  0.21 
Diethylpyrocarbonate (histi-  26  4.07 +  1.16"  30  4.53 ___  1.04" 
dines)  90  36.8 ±  23.6*  59  91.1  ±  239* 
Hydroxylamine reversed  *  1.21  ±  0.30  1.30 ±  0.29 
Reductive methylation (lysines)  46  4,65 ±  1.10  46  1.84 ±  0.38 
81  1.81  ±  0.34  81  0.98 ±  0.12 
Tetranitromethane (phenolic  30  3.71  ±  1.82 
ring of tyrosines)  48  No inhibition  48  4.60 ±  1.46" 
N-Acetylimidazole (phenolic hy-  11  19.8 ±  11.0"  14  4.78 ±  1.92* 
droxyl group of tyrosines) 
Hydroxylamine reversed  3.71  ±  1.89  0.51  ±  0.17 
* Extrapolated KDs0. See legend to Fig. 1 and Table I. 
Refers to 26 and 30% modified IgG for inhibition of  JJ and EG IgG-RF, respectively. 
spectroscopy, tyrosines were not modified. The degree of amino group substi- 
tutions was determined by the trinitrobenzenesulfonic acid assay (21). Modifica- 
tions of up to 81% of the lysines on IgG caused no decrease in the ability of IgG 
to inhibit the binding of IgG-RF to the solid-phase antigens (Table II). Modifi- 
cations of up to 86% of the lysines on JJ IgG-RF, and 79% of the lysines on EG 
IgG-RF reduced their ability to bind by 21% and 51%, respectively (Table III). 
Thus, lysines are not involved on the antigen sides of the interactions. It is likely 
they are not directly involved on the antibody sides of the interactions either, 
but  rather,  extensive  modification  may have  caused  conformational  changes 
resulting in a partial decrease of antibody binding. 
To explore the role of tyrosines in the bindings, two reagents, tetranitrome- 
thane and N-acetylimidazole, were used for chemical modifications. Under mild 
conditions, tetranitromethane causes nitration of the phenolic ring of tyrosine, 
which can be followed spectrophotometrically (22).  Modification of up to 48% 
of tyrosines caused a  significant decrease in  the ability of IgG  to  inhibit  the 
binding of the IgG-RF to solid-phase IgG (Table II). Likewise, modification of 
57% of the tyrosines on JJ IgG-RF reduced its binding by 52%  (Table III). N- 
acetylimidazole reacts preferentially with tyrosyl residues by acetylating phenolic 
hydroxyl groups. This modification is also reversible with hydroxylamine (23). 
Modification of 11%  and  14%  of the tyrosines on IgG preparations decreased 
their ability to inhibit JJ and EG IgG-RF binding to solid phase IgG. Restoration 
of inhibition to near normal levels occurred after treatment with hydroxylamine 
(Table II). Modification of tyrosines on IgG-RF markedly reduced their ability NARDELLA  ET  AL. 
TABLE  III 
Binding of Chemically Modified '25I-jJ and -EG IgG-RF to Solid-phase IgG 
1819 
Modification 
jj  E6 
Binding  Degree of  Binding 
Degree of  (percent of  (percent of 
modifica-  modifica-  control _  control ±  tion  tion  SE)*  SE)* 
%  % 
Unmodified RF  --  100 ±  21  --  100 ___ 8 
Diethylpyrocarbonate (histi-  29  125 ±  23  50  82 4- 9 
dines)  58  101  ±  22  89  65 ±  5 
Reductive methylation (lysines)  43  79 ±  2  42  68 ±  10 
86  90±3  79  49±  10 
Tetranitromethane (phenolic  14  70 ±  6 
ring of tyrosines)  57  48 ±  8 
N-Acetylimidazole  (phenolic hy-  6  2 ±  9  ND  12 ±  5 
droxyl groups of tyrosines) 
Hydroxylamine reversed  43 +  8  ND  57 +  7 
* Maximum  percent  binding  of  unmodified  IgG  RF  is  designated as  100%.  The 
maximum binding of  the IgG RF after chemical modifications  is relative to unmodified 
IgG RF. The standard errors of percent bindings were calculated from the data by a 
formula for propagation of error (35).  ND, not determined. 
to bind to solid phase antigen. Treatment with hydroxylamine partially restored 
this  binding  (Table  II|).  These  studies  indicated involvement of Tyr on  the 
antigen and on the antibody sides of the RF-antigen interactions. Of the nine 
Tyr on the Fc portion of each 3' chain of IgG1 EU, only Tyr 436 is in the C3"2- 
C3"3 interface region (27) (Fig. 3A). This residue is also involved in binding SPA 
(13, 14) (Fig. 3, B and C). 
Discussion 
We have shown that amino acids His 435,  Tyr 436,  and one or both of His 
310 and His 433  are involved in the antigenic determinant for self-associating 
IgG-RF. The accessible atoms of these residues form an ellipse with semiaxes 9.6 
and 13.0 A that describes the size of this region of the Fc fragment. This is only 
slightly larger than the cylindrical radius of 8.4  .~ described by Novotny et al. 
(28) for antigen-binding sites of antibodies. By the same analysis, the region that 
binds SPA is  larger,  with semiaxes of 12.1  and  16.6  A.  These considerations 
indicate that the antigenic site for RF occupy a  subarea of the larger site that 
binds SPA. 
Previous studies from these laboratories (2) indicated a self-association of the 
IgG-RF from patients with rheumatoid arthritis.  Dimers of self-associated IgG- 
RF were observed that underwent concentration-dependent polymerization. A 
model was proposed that accounted for the stability of dimers by the formation FIGURE 3.  Drawings of the Fc regions and details of the binding site for SPA and IgG-RF. 
(A) a-carbon positions (C)), and centers of the hexose units (0) of the Fc fragment of human 
IgG, redrawn with permission from Huber et al. (27). Histidyl residues are denoted by •  and 
tyrosyl  residues  by I.  The  region  of the  SPA  site  is  designated by  the  stippled area.  (B) 
Schematic orientation of the residues  shown  in the stereo  diagram  in C.  The  residues are 
drawn from the t3-carbon, and the backbone is given by a  solid line between carbon atoms. 
The single-letter code is used for residue names. (C) Stereo pair diagram of the ½Fc fragment 
shown in A. For clarity, the molecule has been rotated relative to its position in A. Every 20th 
residue is numbered.  The atomic shading is (from  light to dark) oxygen,  sulfur,  nitrogen, 
carbon. The amino acid side chain residues shown are shielded by >20 A.  when fragment B 
of SPA is contacted (14). NARDELLA ET  AL.  1821 
of two antigen-antibody  bonds between two IgG-RF molecules. The polymeri- 
zation of dimers to higher molecular forms, however, proceeded with an associ- 
ation  constant  of ~105/M,  which  is  that  expected  for  one  RF-antigen  bond. 
Three observations must be considered in proposing a molecular model for self- 
association of IgG-RF. First, as just explained,  the cyclic dimer is the basic unit 
for further polymerization (2). Second, previous studies (11) and current obser- 
vations  showed  that  normal  IgG  was  functionally  monovalent  for  interaction 
with Fab fragments of IgG-RF. On the other hand,  the Fc fragments of normal 
IgG and of IgG-RF were bivalent, suggesting that when a Fab region of IgG-RF 
bound  to  lgG,  the  Fab  arms  of IgG  were  shifted,  and  sterically  blocked  the 
second antigenic site. In the self-association of IgG-RF, however, polymers higher 
than dimers were formed (2). Therefore, the second antigenic determinant must 
be available in some of the self-associated IgG-RF molecules. Third, the location 
of the antigenic site on the Fc fragment,  as determined herein,  makes an angle 
of 53 ° relative to the axis between the amino-terminal  domains in the Fab arms 
of the model of IgG Dob (29). To form the cyclic dimer of two IgG-RF molecules 
proposed earlier (2), molecular motion of the Fab arms and a resultant strain are 
necessary.  The  subsequent molecular  distortion  most  likely dissipates  some of 
the bonding energy, and  may induce the exposure of the second antigenic  site 
to allow further  polymer formation.  Furthermore,  the resultant  conformation 
may allow only one RF-antigen interaction  in the polymerization of dimers. 
The  currently  available  data  do not  provide sufficient detail  to  construct  a 
complete molecular model for self-association of IgG-RF or to account for the 
monovalence of IgG for interaction with IgG-RF. The rotation and contraction 
of the hinge region proposed by Huber et al. (27) appears to expose the antigenic 
sites  we  have  identified.  This  would  explain  the  bivalence  of IgG-RF  in  self- 
association, but does not address the univalence of IgG for interaction with IgG- 
RF. Another possible explanation  of the monovalency of IgG is that the config- 
uration of the Fc fragment changes upon combination with antibody in the C'y2- 
C3~3 region.  Since the  binding  free energy is only 7  kcal/mole or less for one 
RF-antigen bond formation, and since major changes in conformation of the Fc 
were not observed in the higher energy binding of the fragment B of SPA in the 
crystallographic work (13),  this possibility seems remote.  Finally,  we have con- 
structed  semiflexible styrofoam models using the  coordinate  data  of IgG  Dob 
(29). In these models, the binding of an Fab fragment of IgG-RF to the identified 
antigenic site could displace the Fab arms, depending on the angle between the 
two ligands, and thus account for the observed monovalence of normal IgG, as 
originally proposed (11). 
Abundant  evidence indicates  that  RF play an  important  role  in  rheumatoid 
arthritis.  Chronic antigenic stimulation of humans with various infectious agents, 
including  bacteria,  has been associated with  the  development of RF (30).  The 
cause of RF production in rheumatoid arthritis,  however, remains unknown. We 
describe here studies that  indicate  that  the binding  site for some IgG-RF is in 
the same location on the Fc region of IgG, and involves some of the same amino 
acid side chains as the binding of a bacterial cell wall protein, SPA. Furthermore, 
this site is likely to be the same as the Ga determinant,  described for IgM-RF, 
since that site was also present on IgG1, -2, and -4, and not on IgG3 molecules, 1822  IgG  RHEUMATOID FACTOR AND STAPHYLOCOCCAL PROTEIN A 
and was absent from the C3'3  domain (pFc'  fragments) (31).  Although much is 
known  about  the  biochemistry  of SPA binding  to  IgG,  comparatively  little  is 
understood  about  the  role  of SPA  in  staphylococcal  infections,  Cell  surface 
proteins of bacteria are important in the immune response of the host and to the 
virulence  factors  of bacteria.  The  studies  presented  here  suggest a  biological 
relationship  between bacterial  cell  surface  proteins  that  bind  to  IgG  and  the 
production  of RF.  We  speculate  that  Fc-binding  proteins  of other  infectious 
agents may bind to this same location.  Based on the internal  image concept of 
Jerne (32), others (33, 34) have speculated that autoantibodies arise as autoanti- 
idiotypes to antibodies against certain pathogens.  The relationship between RF 
and SPA described here raises the testable hypothesis that RF arise as autoanti- 
idiotypes to antibodies directed against Fc-binding proteins of infectious agents. 
If such  mechanisms  exist,  the  autoantiidiotypic  responses  may  well  be  under 
genetic control,  which may explain  the association of rheumatoid arthritis  with 
certain histocompatibility antigens. 
Summary 
The  antigenic  determinant  on  the  Fc  region  of human  IgG  for  two  IgG 
rheumatoid factors (IgG-RF) from patients with rheumatoid arthritis were inves- 
tigated in detail. The RF did not interact with IgG fragments that contained the 
C3'2 or C3'3 region alone, but required the presence of both regions for binding. 
The RF binding to solid-phase IgG were poorly inhibited by the IgG3 subclass 
and strongly inhibited by staphylococcal protein A (SPA) (42 kD), and fragment 
D  of SPA (7 kD), indicating  that the binding site is most likely the same as the 
Ga antigenic  determinant  described for IgM-RF, and is in the same location as 
the site on lgG that  binds SPA. pH titration  studies of the RF binding  to IgG 
indicated the involvement of histidine and lysine or tyrosine side chains. Chemical 
modification studies showed the histidines  were involved on the  Fc side of the 
interactions,  and  tyrosines  were  involved on  both  the  antigenic  and  antibody 
sides of the interactions.  Lysines were not involved. The above information, and 
the knowledge of the number and position in space of the amino acid residues 
involved in the C3'2-C3,3  interface region of IgG, the binding site for SPA, and 
the amino acid substitutions in IgG3 that account for its inability to bind protein 
A, allowed the identification of the site on IgG that bind IgG-RF. This binding 
site involves some of the  same amino acid side chains,  His 435,  Tyr 436, and 
one or both His 433 and 310, and is in the same location as the site that binds 
SPA.  The  same site is likely to be a  common  antigenic  determinant  for other 
RF.  Furthermore,  the  described  molecular  mimicry  suggests a  biological rela- 
tionship  between  bacterial  Fc-binding  proteins  and  the  production  of RF  in 
rheumatoid arthritis. 
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